cladribine has been researched along with Immunologic Deficiency Syndromes in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golomb, HM; Platanias, LC | 1 |
| Bosly, A; Delannoy, A; Ferrant, A; Filleul, B; Martiat, P; Michaux, JL; Mineur, P; Montfort, L; Straetmans, N; Van Den Neste, E; Vandercam, B | 1 |
| Kipps, TJ | 1 |
| Golde, DW; Lill, MC | 1 |
3 review(s) available for cladribine and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Hairy cell leukaemia.
Topics: Adult; Cladribine; Clinical Trials as Topic; Female; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon-alpha; Leukemia, Hairy Cell; Male; Middle Aged; Pancytopenia; Pentostatin; Prognosis; Remission Induction; Splenectomy; Splenomegaly; Treatment Outcome | 1993 |
Chronic lymphocytic leukemia.
Topics: Adult; Antibodies, Monoclonal; Antigens, CD; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; CD79 Antigens; Chromosome Aberrations; Chromosomes, Human; Cladribine; Combined Modality Therapy; Cytokines; Female; Genes, Immunoglobulin; Genes, p53; Genetic Therapy; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Neoplastic Stem Cells; Prognosis; Risk Factors; Vidarabine | 2000 |
Treatment of hairy-cell leukemia.
Topics: 2-Chloroadenosine; Antibody Formation; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Deoxyadenosines; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Retrospective Studies; Splenectomy | 1990 |
1 trial(s) available for cladribine and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Treatment of hairy-cell leukemia.
Topics: 2-Chloroadenosine; Antibody Formation; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Deoxyadenosines; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon Type I; Leukemia, Hairy Cell; Pentostatin; Remission Induction; Retrospective Studies; Splenectomy | 1990 |
1 other study(ies) available for cladribine and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Infectious complications after 2-chlorodeoxyadenosine therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Cohort Studies; Disease Susceptibility; Female; Fever; Hematologic Diseases; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Incidence; Infections; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Risk Factors; Waldenstrom Macroglobulinemia | 1996 |